title: [Treatment of liver and lung metastases from colorectal cancer].
abstract: Metastases from colorectal cancer are most often confined to the liver or lungs, in which 20-25% may be resected with curative intent. Without treatment, no patients are alive after four years, whereas 30% are alive four years after radical resection. Early use of chemotherapy increases survival, and about 20% of patients may thus become suited for local therapy. After the primary operation, surveillance is recommended, with measurement of carcinoembryonal antigene every 3-6 months for 3 years, then every 6-12 months from years 3 to 5, plus ultrasound or CT scan every 6 months for 3 years, then yearly for up to 5 years.
authors.affiliation: Amtssygehuset i Herlev, Kirurgisk-gastroenterologisk Afdeling. flbu@herlevhosp.kbhamt.dk
authors.forename: Flemming
authors.initials: F
authors.lastname: Burcharth
authors.forename: Benny Vittrup
authors.initials: BV
authors.lastname: Jensen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D017115:Catheter Ablation; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D008175:Lung Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011379:Prognosis; D018714:Radiotherapy, Adjuvant